MGI Tech Unveils High-Throughput Sequencer DNBSEQ-T7+

September 15, 2025
MGI Tech Co., Ltd. has launched the DNBSEQ-T7+, a high-throughput sequencer designed for large-scale genomic research, offering over 14 terabases of data per day.

MGI Tech Co., Ltd. has introduced the DNBSEQ-T7+, a next-generation high-throughput sequencer, announced in a press release. The T7+ is engineered to meet the increasing demand for large-scale genomic research, delivering more than 14 terabases of data in just 24 hours.

The DNBSEQ-T7+ features a compact design with flexible run configurations and end-to-end automation. It integrates MGI's proprietary DNBSEQ™ technology with advanced fluidics, optics, and bioinformatics, creating a platform that is faster and more versatile. The system supports 1–4 flow cells per run and adapts to projects of any scale, integrating every step from DNB preparation to bioinformatics analysis into a fully automated workflow.

Key technical highlights of the T7+ include a throughput of more than 14 terabases per day, an annual capacity of up to 35,000 whole-genome sequences, and accuracy validated with over 90% Q40 quality scores. The sequencer also offers reduced energy consumption and a smaller footprint, making it a powerful tool for accelerating breakthroughs in cancer genomics, rare disease research, and precision medicine.

The DNBSEQ-T7+ is now available for order, with international shipments expected to begin in late 2025.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

09/15
BEVIMI Launches at CG Well Summit with Focus on Cognitive Health
09/15
Armor Health Partners with Antidote-AI for Correctional Healthcare AI Tools
09/12
Cardinality.ai Introduces CardyCares for Enhanced Healthcare Management
09/12
Imaging Endpoints Files Patent for AI-Enhanced Imaging Review System
09/12
Homecare Homebase and Element5 Partner to Enhance Post-Acute Care with AI

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like